BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 5568810)

  • 1. Biotransformation of diphenoxylate in rat and dog.
    Karim A; Garden G; Trager W
    J Pharmacol Exp Ther; 1971 Jun; 177(3):546-55. PubMed ID: 5568810
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of diphenoxylate in man.
    Karim A; Ranney RE; Evensen KL; Clark ML
    Clin Pharmacol Ther; 1972; 13(3):407-19. PubMed ID: 5026379
    [No Abstract]   [Full Text] [Related]  

  • 3. Difenoxine (R15403), the active metabolite of diphenoxylate (R1132). 1. The excretion and metabolism in rats of difenoxine, the pharmacologically active metabolite of the antidiarrheal agent diphenoxylate.
    van Wijngaarden I; Soudijn W
    Arzneimittelforschung; 1972 Mar; 22(3):513-6. PubMed ID: 5067919
    [No Abstract]   [Full Text] [Related]  

  • 4. Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 4. Distribution in the rat of diphenoxylate and difenoxine.
    Heykants JJ; Lewi PJ; Janssen PA
    Arzneimittelforschung; 1972 Mar; 22(3):520-6. PubMed ID: 5067922
    [No Abstract]   [Full Text] [Related]  

  • 5. Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 6. Absorption, excretion and metabolism in man.
    Heykants J; Brugmans J; Verhaegen H
    Arzneimittelforschung; 1972 Mar; 22(3):529-31. PubMed ID: 5067923
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption, distribution, biotransformation, and excretion of azidocillin, a new semi-synthetic penicillin, in mice, rats and dogs.
    Ramsay CH; Bodin NO; Hansson E
    Arzneimittelforschung; 1972 Nov; 22(11):1962-70. PubMed ID: 4633590
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man.
    Hucker HB; Grady LT; Michniewicz BM; Stauffer SC; White SE; Maha GE; McMahon FG
    J Pharmacol Exp Ther; 1971 Nov; 179(2):359-71. PubMed ID: 5002483
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ; Chando TJ; Weliky I; Schreiber EC
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Animal experiments on pharmacokinetic and biotransformation of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].
    Duhm B; Maul W; Medenwald H; Patzschke K; Wegner LA
    Arzneimittelforschung; 1972 Jan; 22(1):42-53. PubMed ID: 5066997
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism and disposition of methylphenidate-14C: studies in man and animals.
    Faraj BA; Israili ZH; Perel JM; Jenkins ML; Holtzman SG; Cucinell SA; Dayton PG
    J Pharmacol Exp Ther; 1974 Dec; 191(3):535-47. PubMed ID: 4473537
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of tinidazole in the rat and dog.
    Wood BA; Rycroft D; Monro AM
    Xenobiotica; 1973 Dec; 3(12):801-12. PubMed ID: 4786681
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biotransformation of prenylamine in rats].
    Volz M
    Arzneimittelforschung; 1971 Sep; 21(9):1320-9. PubMed ID: 5171786
    [No Abstract]   [Full Text] [Related]  

  • 13. The disposition of butriptyline in rats, dogs and man.
    Cameron BD; Chasscaud LF; Lewis JD; Taylor T
    Arzneimittelforschung; 1974 Jan; 24(1):93-6. PubMed ID: 4406119
    [No Abstract]   [Full Text] [Related]  

  • 14. The biologic disposition of pentazocine in the rat.
    el-Mazati AM; Way EL
    J Pharmacol Exp Ther; 1971 May; 177(2):332-41. PubMed ID: 5568791
    [No Abstract]   [Full Text] [Related]  

  • 15. The metabolism of chlorpheniramine maleate in the dog and rat.
    Peets EA; Weinstein R; Billard W; Symchowicz S
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):172-90. PubMed ID: 5072184
    [No Abstract]   [Full Text] [Related]  

  • 16. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate.
    Karim A; Ranney RE; Kraychy S
    J Pharm Sci; 1972 Jun; 61(6):888-93. PubMed ID: 5046104
    [No Abstract]   [Full Text] [Related]  

  • 17. Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog.
    Dreyfuss J; Ross JJ; Schreiber EC
    J Pharm Sci; 1971 Jun; 60(6):829-33. PubMed ID: 5128931
    [No Abstract]   [Full Text] [Related]  

  • 18. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resorption, excretion and biotransformation in dogs and rabbits, biotransformation in man of (methyl-10 phenothiazinyl-2) acetic acid (methiazinic acid--16091 R. P)].
    Populaire P; Terlain B; Pascal S; Lebreton G; Decouvelaere B
    Arzneimittelforschung; 1969 Aug; 19(8):1214-21. PubMed ID: 5820286
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.
    Musa MN; Lower GM; Welling PG; Johnson BM; Kaiman BD; Bryan GT
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.